Skip to main content

Lung: Krascendo-1

Trial ID
06497556
Trial Sponsor
Hoffman-La Roche

Lung: Krascendo-1 (BO45217)

Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Patients with Previously Treated KRAS G12C-Positive Advanced or Metastatic Non-Small Cell Lung Cancer